A Portland medical technology startup, MedRhythms Inc., is continuing to develop its product pipeline with the formation of two scientific advisory boards and the start of a new clinical trial.
MedRhythms, whose patented digital platform uses music and biosensors to treat neurologically linked walking impairment, has created boards to guide the company’s product research in multiple sclerosis and Parkinson’s disease, according to a news release Tuesday. Read more
The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...
Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...
The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...